Antiviral factors and type I/III interferon expression associated with regulatory factors in the oral epithelial cells from HIV-1-serodiscordant couples

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Cervantes, Cesar A C ^a   Oliveira, Luanda M S ^a   Manfrere, Kelly C G ^a   Lima, Josenilson F ^a   Pereira, Natalli Z ^a   Duarte, Alberto J S ^a   Sato, Maria N ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; BETA INTERFERON; GAMMA INTERFERON; IFNG PROTEIN, HUMAN;

ADAPTIVE IMMUNITY; ADULT; COMPARATIVE STUDY; CYTOLOGY; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; MALE; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; MOUTH; SERODIAGNOSIS; SEXUALITY; VIROLOGY;

ADAPTIVE IMMUNITY; ADULT; ANTIVIRAL AGENTS; EPITHELIAL CELLS; FEMALE; HIV INFECTIONS; HIV SERONEGATIVITY; HUMANS; INTERFERON-ALPHA; INTERFERON-BETA; INTERFERON-GAMMA; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; MOUTH; SEXUAL PARTNERS;

EID: 84967190662     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep25875     Document Type: Article

References (43)

1. Miyazawa, M., Tsuji-Kawahara, S., & Kanari, Y. Host genetic factors that control immune responses to retrovirus infections. Vaccine 26, 2981-2996, doi: 10.1016/j.vaccine.2008.01.004 (2008).
2. Lederman, M. M., et al. Determinants of protection among HIV-exposed seronegative persons: an overview. J Infect Dis 202 Suppl 3, S333-338, doi: 10.1086/655967 (2010).
3. Tomescu, C., Abdulhaqq, S., & Montaner, L. J. Evidence for the innate immune response as a correlate of protection in human immunodeficiency virus (HIV)-1 highly exposed seronegative subjects (HESN). Clin Exp Immunol 164, 158-169, doi: 10.1111/j.1365-2249.2011.04379.x (2011).
4. Poudrier, J., Thibodeau, V., & Roger, M. Natural Immunity to HIV: a delicate balance between strength and control. Clin Dev Immunol 2012, 875821, doi: 10.1155/2012/875821 (2012).
5. Biasin, M., et al. TLR activation pathways in HIV-1-exposed seronegative individuals. J Immunol 184, 2710-2717, doi: 10.4049/jimmunol.0902463 (2010).
6. Rowland-Jones, S., et al. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nat Med 1, 59-64 (1995).
7. Jennes, W., et al. Cutting edge: resistance to HIV-1 infection among African female sex workers is associated with inhibitory KIR in the absence of their HLA ligands. J Immunol 177, 6588-6592 (2006).
8. Dorrell, L., et al. Absence of specific mucosal antibody responses in HIV-exposed uninfected sex workers from the Gambia. AIDS 14, 1117-1122 (2000).
9. Clerici, M., et al. Serum IgA of HIV-exposed uninfected individuals inhibit HIV through recognition of a region within the alphahelix of gp41. AIDS 16, 1731-1741 (2002).
10. Makedonas, G., et al. Comparison of HIV-specific CD8 T-cell responses among uninfected individuals exposed to HIV parenterally and mucosally. AIDS 19, 251-259 (2005).
11. Begaud, E., et al. Reduced CD4 T cell activation and in vitro susceptibility to HIV-1 infection in exposed uninfected Central Africans. Retrovirology 3, 35, doi: 10.1186/1742-4690-3-35 (2006).
12. Farquhar, C., et al. Salivary human immunodeficiency virus (HIV)-1-specific immunoglobulin A in HIV-1-exposed infants in Kenya. Clin Exp Immunol 153, 37-43, doi: 10.1111/j.1365-2249.2008.03664.x (2008).
13. Lima, J. F., et al. Distinct natural killer cells in HIV-exposed seronegative subjects with effector cytotoxic CD56(dim) and CD56(bright) cells and memory-like CD57+NKG2C+CD56(dim) cells. J. Acquir. Immune Defic. Syndr. 67, 463-471, doi: 10.1097/QAI.0000000000000350 (2014).
14. Oliveira, L. M., et al. Increased frequency of circulating Tc22/Th22 cells and polyfunctional CD38(-) T cells in HIV-exposed uninfected subjects. Sci Rep 5, 13883, doi: 10.1038/srep13883 (2015).
15. Cardoso, E. C., et al. TLR7/TLR8 activation restores defective cytokine secretion by myeloid dendritic cells but not by plasmacytoid dendritic cells in HIV-infected pregnant women and newborns. PloS one 8, e67036, doi: 10.1371/journal.pone.0067036 (2013).
16. Pereira, N. Z., et al. Upregulation of innate antiviral restricting factor expression in the cord blood and decidual tissue of HIVinfected mothers. PloS one 8, e84917, doi: 10.1371/journal.pone.0084917 (2013).
17. Sheehy, A. M., Gaddis, N. C., Choi, J. D., & Malim, M. H. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418, 646-650, doi: 10.1038/nature00939 (2002).
18. Vazquez-Perez, J. A., Ormsby, C. E., Hernandez-Juan, R., Torres, K. J., & Reyes-Teran, G. APOBEC3G mRNA expression in exposed seronegative and early stage HIV infected individuals decreases with removal of exposure and with disease progression. Retrovirology 6, 23, doi: 10.1186/1742-4690-6-23 (2009).
19. Sze, A., Olagnier, D., Lin, R., van Grevenynghe, J., & Hiscott, J. SAMHD1 host restriction factor: a link with innate immune sensing of retrovirus infection. J. Mol. Biol. 425, 4981-4994, doi: 10.1016/j.jmb.2013.10.022 (2013).
20. Stremlau, M., et al. Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor. Proc. Natl. Acad. Sci. USA 103, 5514-5519, doi: 10.1073/pnas.0509996103 (2006).
21. Burdette, D. L., & Vance, R. E. STING and the innate immune response to nucleic acids in the cytosol. Nat. Immunol. 14, 19-26, doi: 10.1038/ni.2491 (2013).
22. Harman, A. N., et al. HIV Blocks Interferon Induction in Human Dendritic Cells and Macrophages by Dysregulation of TBK1. J. Virol. 89, 6575-6584, doi: 10.1128/JVI.00889-15 (2015).
23. Hasan, M., et al. Trex1 regulates lysosomal biogenesis and interferon-independent activation of antiviral genes. Nat. Immunol. 14, 61-71, doi: 10.1038/ni.2475 (2013).
24. Litvak, V., et al. A FOXO3-IRF7 gene regulatory circuit limits inflammatory sequelae of antiviral responses. Nature 490, 421-425, doi: 10.1038/nature11428 (2012).
25. Akhtar, L. N., et al. Suppressor of cytokine signaling 3 inhibits antiviral IFN-beta signaling to enhance HIV-1 replication in macrophages. J Immunol 185, 2393-2404, doi: 10.4049/jimmunol.0903563 (2010).
26. Baggaley, R. F., White, R. G., & Boily, M. C. Systematic review of orogenital HIV-1 transmission probabilities. Int. J. Epidemiol. 37, 1255-1265, doi: 10.1093/ije/dyn151 (2008).
27. Tugizov, S. M., et al. Differential transmission of HIV traversing fetal oral/intestinal epithelia and adult oral epithelia. J. Virol. 86, 2556-2570, doi: 10.1128/JVI.06578-11 (2012).
28. Hasselrot, K., et al. Orally exposed uninfected individuals have systemic anti-HIV responses associating with partners viral load. AIDS 24, 35-43, doi: 10.1097/QAD.0b013e3283329853 (2010).
29. Perez, C. L., Hasselrot, K., Bratt, G., Broliden, K., & Karlsson, A. C. Induction of systemic HIV-1-specific cellular immune responses by oral exposure in the uninfected partner of discordant couples. AIDS 24, 969-974 (2010).
30. Gonzalez, S. M., et al. High expression of antiviral proteins in mucosa from individuals exhibiting resistance to human immunodeficiency virus. PloS one 10, e0131139, doi: 10.1371/journal.pone.0131139 (2015).
31. McClure, R., & Massari, P. TLR-dependent human mucosal epithelial cell responses to microbial pathogens. Front. Immunol. 5, 386, doi: 10.3389/fimmu.2014.00386 (2014).
32. Livak, K. J., & Schmittgen, T. D. Analysis of relative gene expression data using real-Time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402-408, doi: 10.1006/meth.2001.1262 (2001).
33. Loo, Y. M., & Gale, M. Viral regulation and evasion of the host response. Curr. Top. Microbiol. Immunol. 316, 295-313 (2007).
34. Niederberger, E., & Geisslinger, G. Proteomics and NF-κ B: an update. Expert Rev. Proteomics. 10, 189-204, doi: 10.1586/epr.13.5 (2013).
35. Kawai, T., & Akira, S. Signaling to NF-kappaB by toll-like receptors. Trends Mol. Med. 13, 460-469, doi: 10.1016/j. molmed.2007.09.002 (2007).
36. Plaeger, S. F., et al. Immune activation in the pathogenesis of treated chronic HIV disease: a workshop summary. AIDS Res. Hum. Retroviruses 28, 469-477, doi: 10.1089/AID.2011.0213 (2012).
37. Li, S., et al. P. gingivalis modulates keratinocytes through FOXO transcription factors. PloS one 8, e78541, doi: 10.1371/journal. pone.0078541 (2013).
38. Sommereyns, C., Paul, S., Staeheli, P., & Michiels, T. IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo. PLoS Pathog. 4, e1000017, doi: 10.1371/journal.ppat.1000017 (2008).
39. Liu, M. Q., et al. IFN-? 3 inhibits HIV infection of macrophages through the JAK-STAT pathway. PloS one 7, e35902, doi: 10.1371/journal.pone.0035902 (2012).
40. Hou, W., et al. Lambda interferon inhibits human immunodeficiency virus type 1 infection of macrophages. J. Virol. 83, 3834-3842, doi: 10.1128/JVI.01773-08 (2009).
41. Miller, R. L., Meng, T. C., & Tomai, M. A. The antiviral activity of Toll-like receptor 7 and 7/8 agonists. Drug News Perspect. 21, 69-87 (2008).
42. Tebit, D. M., Ndembi, N., Weinberg, A., & Quinones-Mateu, M. E. Mucosal transmission of human immunodeficiency virus. Curr. HIV Res. 10, 3-8 (2012).
43. Vacharaksa, A., et al. Oral keratinocytes support non-replicative infection and transfer of harbored HIV-1 to permissive cells. Retrovirology 5, 66, doi: 10.1186/1742-4690-5-66 (2008).